antibiotics and a central registry of antibiotic-resistant infections. The British journal The Lancet refused to publish a rebuttal from the Indian National Centre for Disease Control, claiming lack of space and that the journal's editors felt it would be better placed elsewhere. However, on 12January 2011, the editor of The Lancet, Richard Horton, apologized and acknowledged that naming the resistance enzyme after New Delhi was an "error". Following this, Ajai R. Singh, editor of Mens Sana Monographs, demanded that such 'geographic names giving' be abandoned and replaced by 'scientific name giving'. He proposed changing NDM-1 to PCM (plasmid-encoding carbapenem-resistant metallo-beta-lactamase). Deaths The first reported death due to bacteria expressing the NDM-1 enzyme was recorded in August 2010, when a Belgian man infected while undergoing treatment in a hospital in Pakistan died despite being administered colistin. A doctor involved in his treatment said: "He was involved in a car accident during a trip to Pakistan. He was hospitalised with a major leg injury and then repatriated to Belgium, but he was already infected". In another case, an Indian citizen, died in a hospital because of similar infection. See also Antibiotic resistance List of antibiotic resistant bacteria Medical tourism Methicillin-resistant Staphylococcus aureus MCR-1 Nosocomial infection Transduction (genetics) References External links BBC News Health - Questions&Answers about NDM-1 superbugs National Resistance Alert 3 addendum in UK (PDF) PBS Frontline Oct 22, 2013 Hunting the Nightmare Bacteria Bacterial enzymes Bacteriology Beta-lactam antibiotics EC 3.5.2 Antimicrobial resistance de:Β-Lactamasen#Carbapenemasen